Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-03-20Clinical Trial Update: Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan [Phase 2]
Phase 2 trial of bupropion sustained-release in Japanese patients with major depressive disorder completed; results have been posted.
-
FDA approval · 2009-03-19FDA Approved: FLUOXETINE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the original ANDA for fluoxetine from Alembic Pharmaceuticals Limited, enabling a generic version of fluoxetine to be marketed.
-
FDA approval · 2009-03-19FDA Approved: FLUOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Fluoxetine by Aurobindo Pharma Limited, enabling a generic Fluoxetine product. The approved indica…
-
CLINICAL_TRIALS trial_result · 2009-03-17Clinical Trial Update: A Double-Blind Study of Buprenorphine Treatment of Acute Suicidality [Phase 3]
A Phase 3 double-blind trial tests buprenorphine for acute suicidality in depressed patients; the current study status is unknown.
-
CLINICAL_TRIALS trial_result · 2009-03-13Clinical Trial Update: Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment Response [NA]
A completed clinical trial study investigating how the menstrual cycle affects depressive symptoms and treatment response in individuals wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of SR58611A for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder [Phase 3]
Phase 3 clinical trial assessing the efficacy and safety of SR58611A in adults with major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder [Phase 3]
A Phase 3 clinical trial evaluating SR58611A for relapse prevention in adults with major depressive disorder has completed.
-
FDA approval · 2009-03-11FDA Approved: CITALOPRAM — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
The FDA approved a supplemental application for a generic citalopram product, enabling its market entry. The applicant is Chartwell Governme…
-
FDA approval · 2009-03-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited. This approval authorizes a gene…
-
FDA approval · 2009-03-06FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for citalopram hydrobromide from Aurobindo Pharma Limited, indicating an approved modification to th…
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse [NA]
A completed clinical trial comparing two types of psychotherapy for treating depression with co-occurring substance use disorders; the snipp…
-
CLINICAL_TRIALS trial_result · 2009-03-02Clinical Trial Update: Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers [Phase 3]
This document notes the completion of a Phase 3 clinical trial evaluating fluoxetine as a smoking-cessation aid in depression-prone smokers,…
-
FDA approval · 2009-02-27FDA Approved: CITALOPRAM HYDROBROMIDE — Original Application (Glenmark Therapeutics Inc., USA)
FDA approved Glenmark Therapeutics' generic citalopram hydrobromide under Original Application (ANDA 077654). Indication is major depressive…
-
FDA approval · 2009-02-25FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for sertraline hydrochloride from Aurobindo Pharma Limited, a generic version of the antidepressant …
-
CLINICAL_TRIALS trial_result · 2009-02-25Clinical Trial Update: Improving Depression Treatment for Older Minority Adults [NA]
This clinical trial update reports the completion of a study aimed at improving depression treatment for older minority adults.
-
CLINICAL_TRIALS trial_result · 2009-02-18Clinical Trial Update: Diagnosis of Depression Among Adolescents
A completed clinical trial from the University of Oslo investigating the diagnosis of depression in adolescents.
-
CLINICAL_TRIALS research · 2009-02-18Clinical Trial Update: Changing Minds - Supporting Depressed Elderly People With an Individually Tailored Service Model [Phase 2]
Phase 2 clinical trial update examining an individually tailored service model to support depressed elderly people; the current status of th…
-
CLINICAL_TRIALS trial_result · 2009-02-17Clinical Trial Update: Deep Brain Stimulation for Refractory Major Depression [Phase 3]
A Phase 3 clinical trial evaluating the effectiveness of deep brain stimulation for refractory major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-17Clinical Trial Update: Memory Functioning and Antidepressant Treatment [Phase 3]
A Phase 3 clinical trial evaluating memory functioning in conjunction with antidepressant treatment for Depression and Major Depressive Diso…
-
CLINICAL_TRIALS research · 2009-02-16Clinical Trial Update: Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
This update assesses the reliability and validity of the MINI-KID, a structured interview for diagnosing psychiatric disorders in children a…
-
CLINICAL_TRIALS withdrawal · 2009-02-10Clinical Trial Update: fMRI Investigation of Depression in Patients With Epilepsy
The clinical trial investigating fMRI assessment of depression in patients with epilepsy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: Evaluation of Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression [Phase 1]
Phase 1 clinical trial evaluating the Deep Transcranial Magnetic Stimulation (H-Coil) for treating major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: Comparison of Body Dissatisfaction Among Islamic Veil Practicing (IVP), Non-Complete IVP, and Inconsiderate to IVP Women
A completed clinical trial overseen by Shahid Beheshti University of Medical Sciences examining body dissatisfaction among Islamic veil prac…
-
CLINICAL_TRIALS research · 2009-02-05Clinical Trial Update: End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)
This clinical trial update focuses on end-of-life fear in patients with end-stage lung disease (COPD); no study status or results are provid…